Manuel Stotz Reports 12.02M VERB Shares Held via Kingsway Funds
Rhea-AI Filing Summary
Manuel Stotz filed an initial Form 3 disclosing indirect beneficial ownership of 12,021,720 shares of Verb Technology Company, Inc. (VERB) common stock held through multiple Kingsway-managed funds. The filing lists seven fund holdings with individual amounts ranging from 333,144 to 3,690,399 shares and states that Kingsway Capital Partners Limited acts as investment manager. The reporting person is identified as the Chief Executive Officer of the investment manager and the Chairman of Verb's board. No derivative securities are reported. The transaction date requiring the statement is 08/07/2025 and the form was signed on 08/18/2025.
Positive
- Comprehensive disclosure of indirect holdings totaling 12,021,720 shares across seven named funds
- Clear identification of relationship: Reporting person is CEO of the investment manager and Chairman of the issuer
- No derivative securities reported, indicating holdings are in common stock only
Negative
- None.
Insights
TL;DR: Disclosure shows sizeable indirect stake via Kingsway funds; no derivatives reported, signaling a straightforward ownership position.
The Form 3 documents aggregated indirect beneficial ownership of 12,021,720 shares across seven funds managed by Kingsway Capital Partners Limited. As the reporting person is both the CEO of the investment manager and Chairman of Verb's board, the filing clarifies lines of investment discretion versus formal direct ownership. Absence of listed derivative instruments indicates the position is held in common stock rather than options or convertible securities, simplifying valuation and voting considerations based on disclosed share counts alone.
TL;DR: Chairman discloses indirect holdings through affiliated funds, fulfilling Section 16 reporting obligations and clarifying potential influence.
The report states that Kingsway Capital Partners Limited serves as investment manager to the named funds and that the reporting person may be deemed beneficial owner due to investment discretion. This Form 3 provides required transparency regarding relationships between board leadership and institutional fund ownership. The filing does not allege any amendments or derivative positions, and it includes a manual signature dated 08/18/2025, meeting formal filing conventions.